Date | Time | Source | Headline | Symbol | Company |
03/19/2008 | 2:31PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
03/12/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. to Announce Fourth Quarter and Year-End Financial Results on March 31, 2008 | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/26/2008 | 12:18PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/26/2008 | 12:16PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Ownership (SC 13G) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/14/2008 | 4:05PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/14/2008 | 4:04PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/14/2008 | 3:48PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/13/2008 | 2:33PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/12/2008 | 4:30PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/11/2008 | 9:26AM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
02/06/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. To Present at BIO CEO & Investor Conference | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
01/25/2008 | 3:01PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
01/23/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. To Present at Wachovia 2008 Healthcare Conference | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
01/22/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. to Host Analyst Day Event and Webcast February 5, 2008 | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/30/2007 | 4:47PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/30/2007 | 3:26PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (3/A) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/30/2007 | 3:15PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/28/2007 | 5:07PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/26/2007 | 4:11PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Ownership (SC 13G) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/21/2007 | 6:17PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/21/2007 | 6:05PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/16/2007 | 5:29PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/13/2007 | 5:26PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. (Other) (10-Q) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/13/2007 | 5:08PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. (Other) (8-K) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/13/2007 | 9:45AM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. (Other) (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/09/2007 | 5:01PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
11/09/2007 | 5:01PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
08/16/2007 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Announces Appointment of Donald E. Wallroth as Chief Financial Officer | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
08/13/2007 | 12:55PM | Business Wire | CORRECTING and REPLACING Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2007 Financial Results | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
08/13/2007 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2007 Financial Results | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |